KAM
LLY icon

Kazazian Asset Management’s Eli Lilly LLY Stock Holding History

Kazazian Asset Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7,729
Closed -$645K – 99
2015
Q2 		$645K Sell
7,729
-291
-4% -$22.2K 0.64% 27
2015
Q1 		$583K Buy
8,020
+46
+0.6% +$3.27K 0.77% 25
2014
Q4 		$550K Buy
+7,974
New +$538K 0.48% 39

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Kazazian Asset Management's LLY Position: Q3 2015 in Review

Kazazian Asset Management sold out of Eli Lilly (LLY) in Q3 2015, closing a stake of 7,729 shares — an estimated $645K sold.

Kazazian Asset Management first reported a position in LLY in Q4 2014 and held it in 3 quarters. The position peaked at $645K in Q2 2015. 1,147 funds tracked by Wall St. Rank hold LLY as of Q3 2015.

  • Kazazian Asset Management reported no remaining Eli Lilly position as of Q3 2015 after selling out during the quarter.
  • Kazazian Asset Management sold 7,729 Eli Lilly shares in Q3 2015, an estimated $645K.
  • Kazazian Asset Management first reported a position in Eli Lilly in Q4 2014 and held it in 3 quarters.
  • Kazazian Asset Management's Eli Lilly position peaked at $645K in Q2 2015.
  • 1,147 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2015.

Based on Kazazian Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.